Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association

被引:408
作者
Buse, John B.
Ginsberg, Henry N.
Bakris, George L.
Clark, Nathaniel G.
Costa, Fernando
Eckel, Robert
Fonseca, Vivian
Gerstein, Hertzel C.
Grundy, Scott
Nesto, Richard W.
Pignone, Michael P.
Plutzky, Jorge
Porte, Daniel
Redberg, Rita
Stitzel, Kimberly F.
Stone, Neil J.
机构
关键词
AHA Scientific Statement; cardiovascular diseases; diabetes mellitus; primary prevention;
D O I
10.1161/CIRCULATIONAHA.106.179294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 83 条
[1]   Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2 Veterans Affairs Diabetes Trial [J].
Abraira, C ;
Duckworth, W ;
McCarren, M ;
Emanuele, N ;
Arca, D ;
Reda, D ;
Henderson, W .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (06) :314-322
[2]  
*ACCORD STUD GROUP, 2004, PRACT DIABETOL, V23, P6
[3]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[4]  
*AM COLL END, 2002, ENDOCR PRACT S1, V8, P5
[5]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[7]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[8]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[9]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[10]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278